Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05MJO
|
||||
Former ID |
DNC012145
|
||||
Drug Name |
2-(3-Methyl-piperazin-1-yl)-6-nitro-quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [525836] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H16N4O2
|
||||
Canonical SMILES |
CC1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)[N+](=O)[O-]
|
||||
InChI |
1S/C14H16N4O2/c1-10-9-17(7-6-15-10)14-5-2-11-8-12(18(19)20)3-4-13(11)16-14/h2-5,8,10,15H,6-7,9H2,1H3
|
||||
InChIKey |
WIRIBEHWECMIRC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [525836] | |
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.